(Total Views: 249)
Posted On: 06/08/2022 5:09:45 PM
Post# of 1418
Great two presentation today. I did notice the company clearly stated they own 60% of 3CL Pharma. Maybe they already exercised the option or will, for the other 8%.
$1.98B valuation by a well respected 3rd party.
60% of $1.98B = $1.19B which is what Todos owns.
Do some funding and Todos might be left with $1B.
To me, that is pretty, pretty, pretty good for a company with a market cap likely less than their 2022 projected revenue
Oh and none of this includes the breast cancer test coming next year which will be worth a small fortune.
$1.98B valuation by a well respected 3rd party.
60% of $1.98B = $1.19B which is what Todos owns.
Do some funding and Todos might be left with $1B.
To me, that is pretty, pretty, pretty good for a company with a market cap likely less than their 2022 projected revenue
Oh and none of this includes the breast cancer test coming next year which will be worth a small fortune.
(3)
(0)
